Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany

• 33.0% of patients with autism were prescribed psychotropic drugs in Germany in 2009. • Methylphenidate, risperidone and valproate were the most prevalent substances. • Treatment rates increased with age, from 16.3% (0–4 years) to 55.1% (20–24 years). • From 2004 to 2009, treatment rates rose by 27...

Full description

Bibliographic Details
Published in:Research in developmental disabilities, Vol. 34, No. 9 (2013), p. 2551-2563
Main Author: Bachmann, Christian J.
Other Involved Persons: Manthey, Thomas ; Kamp-Becker, Inge ; Glaeske, Gerd ; Hoffmann, Falk
Format: electronic Article
Language:English
ISSN:1873-3379
Physical Description:Online-Ressource
DOI:10.1016/j.ridd.2013.05.028
QR Code: Show QR Code